CLINICAL_TRIALS
trial_result
· 2018-02-07
Clinical Trial Update: Interleukin-2 in Metastatic Melanoma [Phase 2]
Summary
The Phase 2 trial of Interleukin-2 in metastatic melanoma was terminated; results were posted on 2018-02-07.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Western Regional Medical Center | Conditions: Melanoma Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2018-02-07